AVM is a development-stage biotech company advancing the research, development and commercialization of game-changing stem cell technologies for high unmet medical needs in regenerative medicine, cancer treatment recovery, safer iPS cell culturing and treatment, and fully human biologics, including patient-specific biologics for personalized medicine (“Boutique Biologics™”) in orphan diseases.

Biotechnology

AVM Biotech

Theresa A. Deisher, Ph.D.

Terry Kopp

Mia Lor

Jena Dalpez

Peter Jarzyna

The leadership team at AVM Biotech has a history of working in pharmaceuticals and healthcare. They have experience as postdoctoral fellows at renowned hospitals, and also have worked as hospital pharmacists. Their educational backgrounds are in pharmaceutical chemistry and pharmacy from the University of Regensburg.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at AVM Biotech

Board of Directors

CEO and Executive Team